Related Experiment Video
Updated: May 21, 2026
12:57
X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
Published on: December 9, 2022
16-kDa prolactin and bromocriptine in postpartum cardiomyopathy
Denise Hilfiker-Kleiner1, Ingrid Struman, Melanie Hoch
1Department of Cardiology and Angiology, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany. hilfiker.denise@mh-hannover.de
Current Heart Failure Reports
|June 26, 2012
Summary
Peripartum cardiomyopathy (PPCM) is a serious heart condition linked to oxidative stress and a prolactin (PRL) fragment. Bromocriptine shows promise in preventing and treating PPCM.
Area of Science:
- Cardiology
- Endocrinology
- Reproductive Medicine
Background:
- Peripartum cardiomyopathy (PPCM) is a critical heart condition affecting women late in pregnancy or postpartum.
- Oxidative stress may trigger prolactin (PRL) cleavage into a harmful 16-kDa PRL fragment, implicated in PPCM.
- Bromocriptine, a dopamine D2-receptor agonist, inhibits PRL secretion.
Purpose of the Study:
- To review current knowledge on PPCM diagnosis.
- To explore the role of 16-kDa PRL and bromocriptine in PPCM pathophysiology.
- To outline potential clinical management and treatment strategies for PPCM.
Main Methods:
- Literature review on PPCM diagnosis, 16-kDa PRL, and bromocriptine.
- Analysis of existing data on PPCM animal models and clinical experiences.
- Synthesis of information to inform clinical practice.
Main Results:
- Evidence suggests a link between oxidative stress, 16-kDa PRL, and PPCM development.
- Bromocriptine demonstrated efficacy in preventing PPCM in an animal model.
- Preliminary clinical data indicate positive effects of bromocriptine in PPCM patients.
Conclusions:
- The 16-kDa PRL fragment is a potential key player in PPCM.
- Bromocriptine offers a promising therapeutic avenue for PPCM prevention and treatment.
- Further research is needed to fully elucidate PPCM mechanisms and optimize bromocriptine use.
Related Concept Videos
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...